I Think Johnson & Johnson Is the Best Dividend Stock to Buy Right Now
The company is firing on all cylinders.
There are numerous high-quality dividend stocks available, yet Johnson & Johnson (NYSE: JNJ) currently distinguishes itself among them. The healthcare giant boasts a robust business foundation, and recent developments have further enhanced the stock's appeal. Below are additional insights into why Johnson & Johnson is an appealing dividend stock.
Individual investors possess distinct objectives, risk tolerance levels, and initial capital investments, leading to varied company preferences. However, several shared qualities are sought in dividend stocks. Among these, one of the most crucial criteria for me is the underlying business's financial stability. No other aspect holds significance if the corporation encounters severe challenges it is unlikely to overcome, potentially resulting in dividend reductions or even a temporary suspension of payments. An additional factor I consider is the corporation's dividend history.
Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
